Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Nova Minerals Provides an Invitation to an Investor Webinar
-
Sfil : Press release - 2024 Results now available
-
Form 8.5 (EPT/RI) - Warpaint London Plc
-
Form 8.5 (EPT/RI) - Brand Architekts Group plc
-
TransUnion Collaborates with Credit Sesame to Launch New Freemium Direct-to-Consumer Credit Education and Monitoring Offering
-
Alliance Witan PLC - Net Asset Value
-
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
-
TransUnion Announces Fourth Quarter and Full-Year 2024 Results and Refreshed Capital Allocation Framework
-
Beneficient Reports Results for Third Quarter Fiscal 2025
-
Biz2Credit Small Business Earnings Report Finds SMB’s Average Earnings Dropped Nearly $10K in January 2025
-
Skel fjárfestingafélag hf.: Major Shareholder Announcement - Taconic Capital Advisors L.P.
-
Notice to Convene the Annual General Meeting of Genmab A/S
-
Ormat Technologies Awarded Tolling Agreements for Two Energy Storage Facilities in Israel
-
Mullen Group Ltd. Announces 2024 Fourth Quarter Financial Results and Filing of Disclosure Documents
-
Altus Group Releases its Q4 2024 Pan-European Dataset Analysis on CRE Valuation Trends
-
LXP Industrial Trust Reports Fourth Quarter 2024 Results
-
Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 5, 2025
-
Apptronik Raises $350 Million to Scale Production of AI-Powered Humanoid Robots and Meet Significant Customer Demand
-
Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update
-
Ragnarok Begins (RO仙境傳說:一定要可愛) Official Launching in Taiwan, Hong Kong and Macau on February 13, 2025
-
Vistin Pharma ASA: Key information relating to the proposed cash dividend
-
MT Højgaard Holding A/S: Conference call 20 February at 10.00 CET about FY 2024
-
REPEAT -- G2 Announces Further Exploration Alliances
-
ThinkMarkets Celebrates Its 15-year Anniversary
-
Net Asset Value(s)
-
Dimensional Fund Advisors Ltd. : Form 8.3 - AMERICAN AXLE & MFG HOLDINGS - Ordinary Shares
-
Form 8.3 - Dowlais Group plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - HARGREAVES LANSDOWN PLC - Ordinary Shares
-
Himax Technologies, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results; Provides First Quarter 2025 Guidance
-
David M. Foulkes elected Chairman of Brunswick Corporation Board of Directors in addition to current CEO Role
-
Middlefield Canadian Income PCC - Statement re Notice of Requisition of a General Meeting
-
Scatec closes sale of Vietnam wind power plant to SUSI Asia Energy Transition Fund
-
Man Group PLC : Form 8.3 - Dowlais Group plc
-
Middlefield Canadian Income PCC - Holding(s) in Company
-
FIA PRESIDENT ADDRESSES UNITED NATIONS IN GENEVA CALLING FOR ACTION AROUND INLAND TRANSPORT AND MOBILITY
-
Caisse Française de Financement Local:
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
Bear In Bathrobe ($BIB) Now Listed on ZEBACUS: A New Milestone for the Meme Token Revolution
-
Bibby Financial Services embarks on digital transformation journey with Contentstack to build personalised customer experiences
-
Share Buyback Transaction Details February 6 – February 12, 2025
-
Nissan’s contribution to Renault Group’s Full Year 2024 earnings: €211 million
-
Madsen Mine Site Update: Bulk Sample Underway, Connection Drift 80% Complete, Underground Development and Facility Installs Progressing
-
FE Investments selects technology vendor Jacobi to accelerate growth of its Managed Portfolio Service (MPS)
-
Advantest to Showcase Latest Test Solutions at SEMICON Korea 2025, Feb. 19-21, in Seoul
-
Shutter Network Introduces Plan for First Encrypted Mempool on Ethereum
-
Cytovation Appoints Martin Dewhurst to its Board of Directors
-
Ooredoo Qatar taps Nokia 5G Standalone Core to deliver advanced network services and generate new revenue streams
-
HSBC Continental Europe: Post Stabilisation Notice
-
Cytovation Appoints Martin Dewhurst to its Board of Directors
-
PulseSight Therapeutics Announces First Close of its Series A Financing to Fund Clinical Development of PST-611 in dry AMD

